Markets.com Logo

AUROPHARMA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1057.6407$
  • Previous Close
    1042.8039$
  • 52 Week Change
    579.82$
  • Day Range
    14.84$
  • 52 Week High/Low
    1006.2247$ - 1586.0492$
  • Dividend Per Share
    0
  • Market cap
    604 615 M$
  • EPS
    14.2
  • Beta
    0.132
  • Volume
    --

About

AUROPHARMA.NSE refers to the stock of Aurobindo Pharma Limited, traded on the National Stock Exchange of India (NSE). Aurobindo Pharma is a major Indian pharmaceutical company headquartered in Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The ".NSE" suffix specifically identifies that the stock is listed and traded on the National Stock Exchange. Investors can buy and sell shares of Aurobindo Pharma through the NSE using the AUROPHARMA symbol. The stock's performance is influenced by factors affecting the pharmaceutical industry, company-specific news, and the overall economic climate in India and globally.

Oil Market Paradox: Geopolitical Tensions vs. Stable Prices

Ava Grace|--

US Midterm Elections: Energy Sector Outlook and Investment Implications

Ava Grace|--
Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Bitcoin price analysis: How much will $1 Bitcoin (BTC/USD) be worth in 2030?

Ghko B|--

Howard Marks on Market Cycles, Value Investing Logic, and Current Economic Shifts

Sophia Claire|--
EUR/USD Forecast: EUR/USD Eyes Key Resistance, Will the Dollar Bounce or Continue to Slide?

EUR/USD Forecast: EUR/USD Eyes Key Resistance, Will the Dollar Bounce or Continue to Slide?

Ghko B|--

Market Resilience Amidst Geopolitical Tensions: HSBC's Optimistic Strategic Outlook

Sophia Claire|--
Apple stock analysis: Could Apple stock soar under its new CEO John Ternus?

Apple stock analysis: Could Apple stock soar under its new CEO John Ternus?

Ghko B|--

Factors

Drug Pricing & Regulations: Changes in government drug pricing policies significantly impact revenue.

Raw Material Costs: Fluctuations in the price of active pharmaceutical ingredients (APIs) and other raw materials affect profitability.

Competition: The entry of new players or increased competition in existing markets can erode market share and pricing power.

Regulatory Approvals: Delays or rejections in regulatory approvals for new products can negatively affect future growth prospects.

Global Market Conditions: Economic conditions and healthcare spending patterns in key export markets influence demand.

Currency Exchange Rates: Fluctuations in exchange rates, particularly the USD/INR rate, impact export revenues and profitability.

Company-Specific News: Announcements regarding earnings, new product launches, mergers, and acquisitions directly affect investor sentiment.

Overall Market Sentiment: General market trends and investor risk appetite influence stock valuations.

Research & Development: Success in developing and launching new drugs can drive long-term growth and stock price appreciation.

Manufacturing Issues: Production disruptions or quality control issues can lead to product recalls and decreased sales.

People Also Watch

Latest news

Fed Leadership Uncertainty: Powell's Potential Continuation and Political Hurdles

Ava Grace|--

Gerrymandering Backfires: Republicans Fear Election Losses as Districts Are Redrawn

Emma Rose|--

Fed Nomination Stalemate: Republican Opposition Halts Warsh's Senate Confirmation

Sophia Claire|--

Latest Education Articles

What Are Non-Farm Payrolls? A Simple Guide for Traders

What Are Non-Farm Payrolls? A Simple Guide for Traders

Julian Parker|--
What Is Spread Betting and How Does It Work? A Clear Guide for Traders

What Is Spread Betting and How Does It Work? A Clear Guide for Traders

Julian Parker|--
What Drives Cryptocurrency Prices? 8 Key Factors Traders Should Know

What Drives Cryptocurrency Prices? 8 Key Factors Traders Should Know

Julian Parker|--
Recommended Topics